Market Overview

Oppenheimer Initiates Coverage on Quest Diagnostics Incorporated at Underperform, Announces $53.00 undefined

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for DGX

DateFirmActionFromTo
Jul 2014Canaccord GenuityMaintainsHold
Jul 2014CitigroupMaintainsNeutral
May 2014Bank of AmericaUpgradesUnderperformNeutral

View More Analyst Ratings for DGX
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (DGX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters